Ann: Anatara progressing towards first human clinical studies, page-21

Yeah, I agree, I'm guessing that it hasn't commenced as that is the status on the ObvioHealth website. At this rate the CSIRO trial for 3FDC will start (and finish) before the GaRP one.The whole covid thing has made it hard to judge how deadlines are being met, there must be something behind the delay, I wonder what it is.

I don't think there is much burn at least, in the 7-Apr-21 update they said:"The Company has a strong balance sheet with funding well beyond the trial timeframes and is actively reassessing as a priority both in house and external resources and capabilities to assist with investor relations." Maybe that is the problem, need more resources.

So I think we'll be waiting until the next quarterly for an update, would love to see some uptake on the animal side of things, but have to give it some time with the current resourcing.